
Identiv leads among international companies innovating in data security and the Internet of Things. The company has recently announced that its NFC- enabled syringe jab monitoring solution has been recognized as the 2021 new product of the year in the IoT category by Security Today. The annually awarded recognition from Security Today is aimed at rewarding outstanding innovators in the field of technical applications. It recognizes the innovation that creates better growth opportunities for businesses and industries. The product with the most practical, real-time application wins the new IoT product of the year.
The new NFC empowered fix from Identiv comes with a front-end intelligent touch sensor that measures fill levels. The product is aided by a specific app that works with an inbuilt alarm. The companion app works in simplifying medicine protocol for patients so that prescription programs are easy to follow. The entire system is very intuitive and effective because it has advanced sensors. The product has an easy tap and go-sensor readout that works easily for telemedicine programs and monitoring of prescription programs in the domestic environment.
Since the healthcare industry looks forward to innovation in IoT to usher in an era of public safety and longevity, this solution has been adjudged as the best product in the IoT category for 2021. The product from Identiv has the name of uTrust Sense SyringeCheck. The product won as the best innovation for its role in helping patients take medicines at the correct dose and on time. It is a pioneer product in injectable tech and backed by clinical trials that declare it completely safe for human use. The injectable also supports prescription programs from insurance companies. The injectable makes it easier for the patients to receive medication as it provides in-home injections. This helps the patients tackle the need to visit clinics again and again. This, in turn, helps avoid extra costs and delays for the people.
The in-home service is a necessity in today's time as people battle COVID 19 surge. For patients, it is always advised to get medical attention and care at home to stay at home and avoid the risk of falling sick. With the help of the injectable, doctors can continue clinical trials at home and do not have to meet patients in the clinical setting. On the other hand, the injectable helps identify non-compliant participants in the trial and excludes them from the final study.
The dosing syringe is not the first IoT innovation of Identiv in the healthcare sector. The company has used its NFC capabilities and RFID technology to introduce different innovations in the Medtech sector. Furthermore, the MedTech sector will revolutionize the healthcare sector with time. The different solutions from Identiv apply in different sectors of pharmaceuticals and medical facilities. The different tech applications from Identiv help protect patients' data security.
Moreover, these applications provide contactless services to people in a hospital setting. Thirdly, the technology helps reduce the cost of clinical visits of patients. The large-scale deployment of the technology can create advanced clinical services that come into use even in an at-home environment. Today, when telemedicine and remote patient monitoring is an upcoming space of the application, Identiv's win just cements its place in the healthcare sector and its future.
Credits: For more information, you can check here.
Tanaya is a Senior Content Developer at IoT Avenue who helped to build the content of the site along with several other sites with her compassionate SEO driven content. She is also a HubSpot, certified Content Marketer. She brings her five years of experience to her current role, where she is dedicated to developing the content of different websites.
by Tanaya Sadhukhan | Feb 07, 2022 | IoT News
by Tanaya Sadhukhan | Jan 07, 2022 | IoT News
by Tanaya Sadhukhan | Nov 17, 2021 | IoT News
by Tanaya Sadhukhan | Oct 27, 2021 | IoT News
by Tanaya Sadhukhan | Oct 04, 2021 | IoT News
We use cookies to provide you the best experience on our website. By continuing to use our site, you consent to the use of our cookies Find out more